Metraipolis › archive › dc_17e4dbb9c024

Avutometinib — Europe PMC PMID:42254774

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42254774
DOI
10.1107/s2056989026004482
License (as archived)
solo-consultazione
Archived
2026-11-01T16:26:22.996Z
SHA-256 of the archived text
4c10dbdd67541e5008c7dc05e398b9dc5bc7d28544288cdabe12700ca68dac2f
Stable URL of this page
https://metraipolis.com/documento/dc_17e4dbb9c024

How to cite

Avutometinib — Europe PMC PMID:42254774 — Europe PMC (en), https://europepmc.org/article/MED/42254774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17e4dbb9c024 (Metraipolis archive dc_17e4dbb9c024, sha256 4c10dbdd67541e5008c7dc05e398b9dc5bc7d28544288cdabe12700ca68dac2f)
BibTeX
@misc{dc17e4dbb9c024,
  title = {Avutometinib — Europe PMC PMID:42254774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42254774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17e4dbb9c024; sha256 4c10dbdd67541e5008c7dc05e398b9dc5bc7d28544288cdabe12700ca68dac2f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254774. Agents can read the archived copy with the MCP tool read_document.